New commercial, regulatory heads at Fulcrum

Fulcrum Therapeutics Inc. (NASDAQ:FULC) hired Isabel Kalofonos as chief commercial officer, and Heather Faulds as chief regulatory affairs and quality assurance officer, as the company prepares to submit an NDA for losmapimod to treat facioscapulohumeral muscular dystrophy. Kalofonos was SVP and chief commercial officer at ImmunoGen Inc., and Faulds was SVP, regulatory affairs at Alkermes plc (NASDAQ:ALKS). 

Neurodegenerative diseases company Tiziana Life Sciences Ltd. (NASDAQ:TLSA) named Ivor Elrifi CEO, succeeding acting CEO Gabriele Cerrone, who will remain executive chairman. Elrifi was global head of the patent group at Cooley LLP...